A detailed history of Perigon Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 93,865 shares of ABBV stock, worth $16.6 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
93,865
Previous 93,432 0.46%
Holding current value
$16.6 Million
Previous $16 Million 15.67%
% of portfolio
0.51%
Previous 0.47%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $70,942 - $86,309
433 Added 0.46%
93,865 $18.5 Million
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $556,779 - $650,193
-3,597 Reduced 3.71%
93,432 $16 Million
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $904,581 - $1.03 Million
-5,660 Reduced 5.51%
97,029 $17.7 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $2.07 Million - $2.33 Million
15,053 Added 17.18%
102,689 $15.9 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $203,323 - $235,377
1,522 Added 1.77%
87,636 $13.1 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $6.09 Million - $7.58 Million
45,977 Added 114.55%
86,114 $11.6 Million
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $35,863 - $41,301
248 Added 0.62%
40,137 $6.4 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $1.27 Million - $1.53 Million
9,210 Added 30.02%
39,889 $6.45 Million
Q3 2022

Dec 13, 2022

BUY
$134.21 - $153.93 $592,134 - $679,139
4,412 Added 16.8%
30,679 $4.12 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $110,646 - $140,667
804 Added 3.16%
26,267 $4.02 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $386,833 - $479,951
2,931 Added 13.01%
25,463 $4.13 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $227,859 - $288,307
2,121 Added 10.39%
22,532 $3.05 Million
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $2.17 Million - $2.47 Million
20,411 New
20,411 $2.2 Million
Q3 2021

Oct 25, 2021

SELL
$106.4 - $120.78 $2.16 Million - $2.45 Million
-20,322 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $70,175 - $78,179
667 Added 3.39%
20,322 $2.29 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $235,290 - $259,026
2,300 Added 13.25%
19,655 $2.13 Million
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $167,499 - $226,142
-2,081 Reduced 10.71%
17,355 $1.86 Million
Q3 2020

Nov 03, 2020

SELL
$85.91 - $100.83 $12,714 - $14,922
-148 Reduced 0.76%
19,436 $1.7 Million
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $285,776 - $382,411
3,895 Added 24.83%
19,584 $1.92 Million
Q1 2020

Apr 17, 2020

BUY
$64.5 - $97.79 $137,772 - $208,879
2,136 Added 15.76%
15,689 $1.25 Million
Q4 2019

Jan 13, 2020

BUY
$72.13 - $90.25 $20,845 - $26,082
289 Added 2.18%
13,553 $1.21 Million
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $4,219 - $5,073
67 Added 0.51%
13,264 $988,000
Q2 2019

Aug 05, 2019

SELL
$65.7 - $83.98 $6,241 - $7,978
-95 Reduced 0.71%
13,197 $960,000
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $462 - $544
6 Added 0.05%
13,292 $1.07 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $2,257 - $2,784
-29 Reduced 0.22%
13,286 $1.09 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $142,256 - $158,144
1,600 Added 13.66%
13,315 $1.26 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $19,302 - $22,839
-215 Reduced 1.8%
11,715 $1.09 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $644 - $862
7 Added 0.06%
11,930 $1.13 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $8,956 - $9,821
100 Added 0.85%
11,923 $1.15 Million
Q3 2017

Dec 05, 2017

SELL
$69.85 - $89.22 $33,877 - $43,271
-485 Reduced 3.94%
11,823 $1.05 Million
Q2 2017

Sep 12, 2017

BUY
N/A
12,308 New
12,308 $892,000
Q3 2011

Nov 14, 2022

BUY
N/A
4,412
30,679 $4.12 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.